Mestex Company

Mestex is one of the important clusters for innovative pharmaceutical industries and biotech companies in Europe. Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with osteoarthritis of the knee.
Industry: Biotechnology
Headquarters: Basel, Switzerland

Visit Website
info@mestex.ch
Register and Claim Ownership